Very Low Breast Density on Mammography Worsens Breast Cancer Prognosis
Very low mammographic breast density worsens the prognosis of breast cancer, according to a recent study from the University of Eastern Finland. Researchers published their findings in an article by Masarwah et al in European Radiology.
The lower the breast tissue density, the less fibroglandular tissue there is compared to fat tissue. Disease-free survivals, as well as overall life expectancies, were significantly shorter in women with very-low-density breast tissue in comparison to women with high-density breast tissue.
In the future, these findings may prove significant for the assessment of breast cancer prognosis and treatment planning.
Study Background
The study involved 270 breast cancer patients at Kuopio University Hospital, aged between 32 and 86 years. Breast tissue density was analyzed on the basis of mammographic images obtained at the time of diagnosis. The researchers determined the proportion of dense glandular tissue of the overall breast area. Breast tissue density was categorized as low when the proportion of glandular tissue was below 25% and as very low when the proportion of glandular tissue was below 10%. The study was a 6-year follow-up focusing on the effects of breast tissue density and other mammographic features on breast cancer prognosis.
Study Findings
The results indicate that a very low breast tissue density is an independent poor prognostic factor of breast cancer, regardless of patients’ age, menopausal status, or body mass index. Out of the women with very low breast tissue density, 70.7% were alive at the end of the 6-year follow-up, whereas out of women whose proportion of glandular tissue was higher than 10%, 87.7% were alive at the same time. Lower breast tissue density was also associated with more aggressive, higher-grade tumors.
The results are particularly interesting because dense breast tissue has long been known to be associated with an increased risk of cancer. “It is difficult to detect small tumors when screening dense breasts, and this results in a higher occurrence of clinically detectable interval cancers. In the United States, it is nowadays mandatory to let patients know if they have dense breast tissue. This allows them to choose whether they wish to have further tests, such as a screening ultrasound,” said coauthor Ritva Vanninen, MD, PhD.
“It could be assumed that dense breast tissue would also be associated with a poorer prognosis in patients with a recently diagnosed breast cancer. However, this was not the case in our study, as low breast tissue density specifically weakened the prognosis.”
Amro Masarwah, MD, of Kuopio University Hospital, Finland, is the corresponding author of the European Radiology article.
The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.
